Lei, L., Liu, Y., Xu, Y.-Y., Chen, H.-F., Zhan, P., Wang, W.-X. and Xu, C.-W. (2021) Hepatoidadenocarcinoma of the Lung: Ananalysis of the Surveillance, Epidemiology, and End Results (SEER) Database. Open Medicine, 16, 169-174.
https://doi.org/10.1515/med-2021-0215

has been cited by the following article:

• TITLE: Multi-Metastatic Hepatoid Adenocarcinoma of the Lung: Report of Case

  AUTHORS: Toky Rakotoarivo, Christian Tomboravo, Malala Razakanaivo, Narindra Rajaonarison Ny Ony, Clairette Raharisolo, Florine Rafaramino

  KEYWORDS: Hepatoid Adenocarcinoma, Lung, Chemothérapy, Metastasis

  JOURNAL NAME: Journal of Cancer Therapy, Vol.13 No.5, May 31, 2022

  ABSTRACT: Hepatoid adenocarcinoma of the lung is a rare tumor with a poor prognosis. There are no specific treatment-recommendations for this cancer. We report a 59-year-old man, a former smoker, with this condition. He presented with a cough and computed tomography revealed a pulmonary nodule (50 × 47 × 48 mm) with a right pleural effusion, together with a cerebral right temporal-lobe lesion and a right adrenal lesion. The serum alpha-fetoprotein value was normal. Histological examination via bronchoscopic biopsy revealed an adenocarcinoma. Positive CK7, AE1/AE2, and TTF1 with granular cytoplasmic staining on immunohistochemical study confirmed the diagnosis of hepatoid adenocarcinoma of the lung, stage IV-B. The patient had received chemotherapies (carboplatin-pemetrexed, gemcitabine) and cerebral radiotherapy, but he died at eight months of the treatment as a result of tumor progression.